The Candidates List: Targets and Possible Therapies for Squamous Cell Carcinoma of the Lung
This article was originally published in RPM Report
Executive Summary
The Friends of Cancer Research has identified 16 potential molecular targets and nearly two dozen drugs in development for use in squamous cell carcinoma of the lung. Organizers of a master protocol registrational trial for SCCL hope to select four therapies to test when the study launches in 2014.